Amgen Highlights Earlier Repatha Use at AHA 2026
Thousand Oaks, California, United States, November 9, 2026 Amgen has announced new clinical and health economic findings at the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Thousand Oaks, California, United States, November 9, 2026 Amgen has announced new clinical and health economic findings at the...
New York, New York, USA, November 7, 2026 NYU Grossman School of Medicine and NYU Langone Health have reported...
ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...
